Literature DB >> 34009285

Neuromelanin-Sensitive Magnetic Resonance Imaging as a Proxy Marker for Catecholamine Function in Psychiatry.

Guillermo Horga1,2, Kenneth Wengler1,2, Clifford M Cassidy3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34009285      PMCID： PMC9060608          DOI： 10.1001/jamapsychiatry.2021.0927

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   25.911


× No keyword cloud information.
  9 in total

1.  Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI.

Authors:  Jason Langley; Daniel E Huddleston; Christine J Liu; Xiaoping Hu
Journal:  MAGMA       Date:  2016-09-29       Impact factor: 2.310

2.  Contrast mechanisms associated with neuromelanin-MRI.

Authors:  Paula Trujillo; Paul E Summers; Emanuele Ferrari; Fabio A Zucca; Michela Sturini; Luca T Mainardi; Sergio Cerutti; Alex K Smith; Seth A Smith; Luigi Zecca; Antonella Costa
Journal:  Magn Reson Med       Date:  2016-12-26       Impact factor: 4.668

3.  Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain.

Authors:  Clifford M Cassidy; Fabio A Zucca; Ragy R Girgis; Seth C Baker; Jodi J Weinstein; Madeleine E Sharp; Chiara Bellei; Alice Valmadre; Nora Vanegas; Lawrence S Kegeles; Gary Brucato; Un Jung Kang; David Sulzer; Luigi Zecca; Anissa Abi-Dargham; Guillermo Horga
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-22       Impact factor: 11.205

Review 4.  Multimodal dopamine transporter (DAT) imaging and magnetic resonance imaging (MRI) to characterise early Parkinson's disease.

Authors:  Eleanor Porter; Andreas-Antonios Roussakis; Nicholas P Lao-Kaim; Paola Piccini
Journal:  Parkinsonism Relat Disord       Date:  2020-08-17       Impact factor: 4.891

5.  Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia.

Authors:  Yoshiyuki Watanabe; Hisashi Tanaka; Akio Tsukabe; Yuki Kunitomi; Mitsuo Nishizawa; Ryota Hashimoto; Hidenaga Yamamori; Michiko Fujimoto; Masaki Fukunaga; Noriyuki Tomiyama
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

6.  Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depression.

Authors:  Guillermo Horga; Bret R Rutherford; Kenneth Wengler; Brandon K Ashinoff; Elena Pueraro; Clifford M Cassidy
Journal:  Neuropsychopharmacology       Date:  2020-09-12       Impact factor: 8.294

7.  Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI.

Authors:  Clifford M Cassidy; Kenneth M Carpenter; Anna B Konova; Victoria Cheung; Alexander Grassetti; Luigi Zecca; Anissa Abi-Dargham; Diana Martinez; Guillermo Horga
Journal:  Am J Psychiatry       Date:  2020-08-28       Impact factor: 19.242

Review 8.  Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease.

Authors:  David Sulzer; Clifford Cassidy; Guillermo Horga; Un Jung Kang; Stanley Fahn; Luigi Casella; Gianni Pezzoli; Jason Langley; Xiaoping P Hu; Fabio A Zucca; Ioannis U Isaias; Luigi Zecca
Journal:  NPJ Parkinsons Dis       Date:  2018-04-10

9.  Unraveling the contributions to the neuromelanin-MRI contrast.

Authors:  Nikos Priovoulos; Stan C J van Boxel; Heidi I L Jacobs; Benedikt A Poser; Kamil Uludag; Frans R J Verhey; Dimo Ivanov
Journal:  Brain Struct Funct       Date:  2020-10-22       Impact factor: 3.270
  9 in total
  2 in total

1.  Add-On MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis- the AMEND Trial Protocol.

Authors:  Katharina O Sandström; Olga B Baltzersen; Anouk Marsman; Cecilie K Lemvigh; Vincent O Boer; Kirsten B Bojesen; Mette Ø Nielsen; Henrik Lundell; Daban K Sulaiman; Mikkel E Sørensen; Birgitte Fagerlund; Adrienne C Lahti; Warda T Syeda; Christos Pantelis; Esben T Petersen; Birte Y Glenthøj; Hartwig R Siebner; Bjørn H Ebdrup
Journal:  Front Psychiatry       Date:  2022-05-20       Impact factor: 5.435

Review 2.  Magnetic resonance imaging of the dopamine system in schizophrenia - A scoping review.

Authors:  Julia Schulz; Juliana Zimmermann; Christian Sorg; Aurore Menegaux; Felix Brandl
Journal:  Front Psychiatry       Date:  2022-09-20       Impact factor: 5.435
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.